TP53 and obesity due to melanocortin 4 receptor deficiency: Moreover, the drug-target-pathway-disease network intuitively displayed the potential targets of CRT in treating obesity enriched in the HIF-1 signaling pathway, adipocytokine signaling pathway, AMPK signaling pathway, and p53 signaling pathway (Figure 3C).